WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$3.94B
1-Year Return
29.08%
This Quarter Return
+3.21%
1 Year Return
+29.08%
3 Year Return
+75.24%
5 Year Return
+223.81%
10 Year Return
+334.33%
AUM
$3.42B
AUM Growth
-$187M
(-5.2%)
Cap. Flow
-$309M
Cap. Flow
% of AUM
-9.01%
Top 10 Holdings %
Top 10 Hldgs %
13.07%
Holding
1,192
New
280
Increased
303
Reduced
272
Closed
297
Top Buys
| 1 |
HPP
Hudson Pacific Properties
HPP
|
+$54.2M |
| 2 |
Lamar Advertising Co
LAMR
|
+$51M |
| 3 |
Devon Energy
DVN
|
+$41.8M |
| 4 |
Synovus
SNV
|
+$39.2M |
| 5 |
Dominion Energy
D
|
+$28.4M |
Top Sells
| 1 |
LPT
Liberty Property Trust
LPT
|
+$44.7M |
| 2 |
EQT Corp
EQT
|
+$37.6M |
| 3 |
RPAI
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
|
+$36.1M |
| 4 |
COLE
COLE REAL ESTATE INVESTMENTS, INC COM
COLE
|
+$34.4M |
| 5 |
Lowe's Companies
LOW
|
+$31M |
Sector Composition
| 1 | Real Estate | 18.21% |
| 2 | Energy | 14.37% |
| 3 | Financials | 12.67% |
| 4 | Industrials | 10% |
| 5 | Consumer Discretionary | 7.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Catalyst Pharmaceutical
CPRX
$2.46B
| $226K | ﹤0.01% |
+100,000
| New | +$226K |
|
827
Sangamo Therapeutics
SGMO
$157M
| $226K | ﹤0.01% |
12,500
-570
| -4% | -$10.3K |
|
828
Steris
STE
$24.5B
| $226K | ﹤0.01% |
4,730
-120
| -2% | -$5.73K |
|
829
Incyte
INCY
$16.9B
| $224K | ﹤0.01% |
+4,180
| New | +$224K |
|
830
Halozyme
HALO
$8.87B
| $222K | ﹤0.01% |
17,500
+5,020
| +40% | +$63.7K |
|
|
NUVA
831
DELISTED
NuVasive, Inc.
NUVA
| $222K | ﹤0.01% |
5,770
-1,080
| -16% | -$41.6K |
|
832
Myriad Genetics
MYGN
$643M
| $221K | ﹤0.01% |
6,450
-9,560
| -60% | -$328K |
|
|
BALT
833
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
| $220K | ﹤0.01% |
+34,880
| New | +$220K |
|
|
RPTP
834
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $220K | ﹤0.01% |
22,000
+8,210
| +60% | +$82.1K |
|
835
Charles River Laboratories
CRL
$7.97B
| $218K | ﹤0.01% |
3,610
-630
| -15% | -$38K |
|
|
IMGN
836
DELISTED
Immunogen Inc
IMGN
| $217K | ﹤0.01% |
14,550
+2,630
| +22% | +$39.2K |
|
|
NTUS
837
DELISTED
Natus Medical Inc
NTUS
| $217K | ﹤0.01% |
+8,430
| New | +$217K |
|
838
Masimo
MASI
$8.08B
| $215K | ﹤0.01% |
7,870
+120
| +2% | +$3.28K |
|
839
Sarepta Therapeutics
SRPT
$1.85B
| $215K | ﹤0.01% |
+8,950
| New | +$215K |
|
|
SGEN
840
DELISTED
Seagen Inc. Common Stock
SGEN
| $215K | ﹤0.01% |
+4,720
| New | +$215K |
|
|
PRXL
841
DELISTED
Parexel International Corp
PRXL
| $215K | ﹤0.01% |
3,980
-1,590
| -29% | -$85.9K |
|
|
ARNA
842
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $214K | ﹤0.01% |
3,404
+41
| +1% | +$2.58K |
|
|
ABAX
843
DELISTED
Abaxis Inc
ABAX
| $214K | ﹤0.01% |
+5,500
| New | +$214K |
|
|
ARIA
844
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $212K | ﹤0.01% |
26,310
-99,670
| -79% | -$803K |
|
845
Bio-Rad Laboratories Class A
BIO
$7.86B
| $211K | ﹤0.01% |
+1,650
| New | +$211K |
|
846
Align Technology
ALGN
$9.92B
| $208K | ﹤0.01% |
4,020
| – | – |
|
847
Neogen
NEOG
$1.23B
| $208K | ﹤0.01% |
12,320
+480
| +4% | +$8.1K |
|
|
CDMO
848
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $208K | ﹤0.01% |
+15,624
| New | +$208K |
|
|
CTIC
849
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $208K | ﹤0.01% |
+6,110
| New | +$208K |
|
850
ICU Medical
ICUI
$3.22B
| $207K | ﹤0.01% |
3,460
+90
| +3% | +$5.38K |
|